 |
FEDERAL CIRCUIT VACATES DISTRICT COURT DISMISSAL OF INFRINGEMENT SUIT*
Fraunhofer-Gesellschaft v. Sirius XM Radio Inc., 18-2400
|
October 17, 2019 |
IPO Federal Circuit Summaries |
 |
IPO Comments to ALI on the Restatement of the Law, Copyright Project
|
October 16, 2019 |
Testimony and Comments |
|
FEDERAL CIRCUIT UPHOLDS DISTRICT COURT’S INDEFINITENESS FINDING* *
HZNP Meds. LLC v. Actavis Labs. UT, Inc., 17-2149
|
October 10, 2019 |
IPO Federal Circuit Summaries |
![]() |
MERITS DECISION NOT REQUIRED TO BE PREVAILING PARTY OWED COSTS UNDER RULE 54(d)*
B.E. Tech., L.L.C. v. Facebook, Inc., 18-2356
|
October 09, 2019 |
|
|
NO REASONABLE EXPECTATION OF SUCCESS WHERE PRIOR ART REFERENCES LACKED EFFICACY DATA*
OSI Pharm., LLC v. Apotex Inc., 18-1925
|
October 04, 2019 |
IPO Federal Circuit Summaries |
|
METHOD FOR MANUFACTURING DRIVE SHAFT TO REDUCE VIBRATION WAS PATENT-INELIGIBLE* *
American Axle & Mfg. v. Neapco Holdings, 18-1763
|
October 03, 2019 |
IPO Federal Circuit Summaries |
|
PTAB ERRED IN DENYING PATENT OWNER MOTION FOR LEAVE TO SEEK CERTIFICATE OF CORRECTION DURING PGR*
Honeywell Int’l Inc. v. Arkema Inc., 18-1151
|
October 01, 2019 |
IPO Federal Circuit Summaries |
|
IPO Comments to USPTO on Proposed Patent Fee Adjustments
|
September 30, 2019 |
Testimony and Comments |
 |
IPO Amicus Brief in European Patent Office, Enlarged Board of Appeal G3/19
|
September 30, 2019 |
Amicus Briefs |
|
IPO Comments to U.S. Trade Representative on Notorious Markets
|
September 28, 2019 |
Testimony and Comments |
|
COURT VACATES IPR DECISION THAT DESIGN CLAIMS WERE NOT OBVIOUS*
Campbell Soup Co. v. Gamon Plus, Inc., 18-2029
|
September 26, 2019 |
IPO Federal Circuit Summaries |
|
USPTO TO REVISIT DETERMINATION THAT PATENT QUALIFIED FOR CBM REVIEW*
SIPCO, LLC v. Emerson Elec. Co., 18-1635
|
September 25, 2019 |
IPO Federal Circuit Summaries |
 |
Proposed Resolution Supporting USPTO Rule Permitting Addressing Amendment of Named Real Parties in Interest Without Loss of Petition Date
|
September 24, 2019 |
IPO Board Resolutions |
|
Proposed Resolution Supporting USPTO Rule Addressing Petition Contents and Discovery Practice Re: Real Parties in Interest
|
September 24, 2019 |
IPO Board Resolutions |
|
IPO Testimony Before USPTO’s TPAC re: Proposed Trademark Fees
|
September 23, 2019 |
Testimony and Comments |
 |
Gender Diversity in Innovation Toolkit
|
September 23, 2019 |
IPO Law Journal |
|
IPO Amicus Brief in Romag Fasteners, Inc. v. Fossil, Inc., 18-1233
|
September 20, 2019 |
Amicus Briefs |
|
USPTO CORRECTLY CALCULATED PATENT TERM ADJUSTMENT*
Intra-Cellular Therapies, Inc. v. Iancu, 18-1849
|
September 18, 2019 |
IPO Federal Circuit Summaries |
|
NO FEDERAL QUESTION IN DISPUTE INVOLVING PATENT LICENSING* *
Inspired Dev. Grp. v. Inspired Prod. Grp., LLC, 18-1616
|
September 18, 2019 |
IPO Federal Circuit Summaries |
|
USPTO CORRECTLY CALCULATED TIME SPENT ON CONTINUED EXAMINATION WHEN DETERMINING PATENT TERM ADJUSTMENT* *
Mayo Found. v. Iancu, 18-2031
|
September 16, 2019 |
IPO Federal Circuit Summaries |
|
OST-INSTITUTION ARGUMENTS IN IPR CONSTITUTED NEW THEORY OF UNPATENTABILTY*
Henny Penny Corp. v. Flymaster LLC, 18-1596
|
September 12, 2019 |
IPO Federal Circuit Summaries |
|
COURT PROPERLY RELIED ON CLAIM LANGUAGE TO LIMIT SCOPE OF DESIGN PATENT WHERE ARTICLE OF MANUFACTURE WAS NOT ILLUSTRATED IN THE FIGURES* *
Curver Luxembourg, SARL v. Home Expressions Inc., 18-2214
|
September 12, 2019 |
IPO Federal Circuit Summaries |
|
ANTITRUST CLAIMS RELATED TO PATENT LITIGATION WERE BARRED BY COLLATERAL ESTOPPEL*
Intellectual Ventures I LLC v. Capital One Financial Corp., 18-1367
|
September 10, 2019 |
IPO Federal Circuit Summaries |
|
WHEN STATE ACTS SOLELY AS PLAINTIFF, STATE SOVEREIGNTY DOES NOT AFFECT VENUE* *
Board of Regents v. Boston Scientific Corp., 18-1700
|
September 05, 2019 |
IPO Federal Circuit Summaries |
|
IPO Amicus Brief in European Patent Office, Enlarged Board of Appeal G1/19
|
August 29, 2019 |
Amicus Briefs |
|
DISTRICT COURT CORRECTLY CONSTRUED CLAIM TERM AS LIMITING*
Allergen Sales, LLC v. Sandoz Inc., 18-2207
|
August 29, 2019 |
IPO Federal Circuit Summaries |
|
USPTO DECISION TO TERMINATE IPR PROCEEDINGS NOT REVIEWABLE UNDER 35 U.S.C. 314(d)* *
BioDelivery Scis. Int’l v. Aquestive Therapeutics, Inc., 19-1643
|
August 29, 2019 |
IPO Federal Circuit Summaries |
|
COURT UPHOLDS ITC DECISION THAT ASPEN’S CLAIMS WERE VALID, INFRINGED*
Guandong Alison Hi-Tech Co. v. ITC, 18-2042
|
August 27, 2019 |
IPO Federal Circuit Summaries |
|
IPO Comments to USPTO on Streamlining IDS Regulations
|
August 26, 2019 |
Testimony and Comments |
|
FEDERAL CIRCUIT OVERTURNS INFRINGEMENT VERDICT, FINDING CLAIMS PATENT-INELIGIBLE*
Chamberlain Grp., Inc. v. Techtronic Indus. Co Ltd., 18-2103
|
August 21, 2019 |
IPO Federal Circuit Summaries |
|
USE OF TERM IN FINAL WRITTEN DECISION THAT DID NOT APPEAR IN IPR PETITION DID NOT CONSTITUTE RELIANCE ON NEW THEORY*
Arthrex, Inc. v. Smith & Nephew, Inc., 18-1584
|
August 21, 2019 |
IPO Federal Circuit Summaries |
|
CLAIMS IN SECOND AMENDED COMPLAINT THAT RELATED BACK TO ORIGINAL COMPLAINT WERE NOT TIME-BARRED UNDER § 286*
Anza Tech., Inc. v. Mushkin, Inc., 19-1045
|
August 16, 2019 |
IPO Federal Circuit Summaries |
|
COURT ERRED IN RULING ON PATENT-ELIGIBILITY WITHOUT RESOLVING CLAIM CONSTRUCTION DISPUTE* *
MyMail, Ltd. V. ooVoo, LLC, 18-1758
|
August 16, 2019 |
IPO Federal Circuit Summaries |
|
“SUBSTANTIALLY EQUIVALENT” DISCLOSURE SATISFIED WRITTEN DESCRIPTION REQUIREMENT* *
Nalpropion Pharm. v. Actavis Labs. FL, Inc., 18-1221
|
August 15, 2019 |
IPO Federal Circuit Summaries |
|
NO JURISDICTION OVER PATENT CLAIMS DISCLAIMED DURING CONCURRENT IPR*
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC, 18-1804
|
August 14, 2019 |
IPO Federal Circuit Summaries |
|
COURT UPHOLDS ITC’S DENIAL OF PROPOSED CONSENT ORDER*
Swagway, LLC v. ITC, 18-1672
|
August 14, 2019 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT UPHOLDS DISTRICT COURT CLAIM CONSTRUCTION*
Iridescent Networks, Inc. v. AT&T Mobility, LLC, 18-1449
|
August 12, 2019 |
IPO Federal Circuit Summaries |
|
USPTO ERRED IN INTERPRETING MEANS-PLUS-FUNCTION CLAIM* *
MTD Prods. Inc. v. Iancu, 17-2292
|
August 12, 2019 |
IPO Federal Circuit Summaries |
|
CLAIMS PATENT-INELIGIBLE DESPITE “VALUABLE CONTRIBUTION”*
Genetic Veterinary Scis. v. LABOKLIN GmbH & Co. KG, 18-2056
|
August 09, 2019 |
IPO Federal Circuit Summaries |
|
PROSECUTION HISTORY ESTOPPEL DID NOT BAR RELIANCE ON DOCTRINE OF EQUIVALENTS* *
Eli Lilly & Co. v. Hospira, Inc., 18-2126
|
August 09, 2019 |
IPO Federal Circuit Summaries |
